tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AZN Stock Latest News

AstraZeneca’s Promising Pipeline and Valuation: A Compelling Investment Opportunity
RatingsAstraZeneca’s Promising Pipeline and Valuation: A Compelling Investment Opportunity
2h ago
AZN
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Clinical Success and Strategic Advantages
PremiumRatings
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Clinical Success and Strategic Advantages
6h ago
AZN
Personalis reports data from AstraZeneca phase 3 clinical trial in lung cancer
PremiumThe Fly
Personalis reports data from AstraZeneca phase 3 clinical trial in lung cancer
15h ago
AZN
PSNL
AstraZeneca’s Tozorakimab Study: A Potential Game-Changer for COPD Treatment
PremiumCompany Announcements
AstraZeneca’s Tozorakimab Study: A Potential Game-Changer for COPD Treatment
19h ago
AZN
AstraZeneca’s Observational Study on aHUS in China: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Observational Study on aHUS in China: Key Insights for Investors
19h ago
AZN
AstraZeneca’s Phase III Study on AZD0780: A Potential Game-Changer in Cardiovascular Treatment
PremiumCompany AnnouncementsAstraZeneca’s Phase III Study on AZD0780: A Potential Game-Changer in Cardiovascular Treatment
19h ago
AZN
AstraZeneca’s PRIMULA Lac Study: A Key Update for Anifrolumab Users
Premium
Company Announcements
AstraZeneca’s PRIMULA Lac Study: A Key Update for Anifrolumab Users
19h ago
AZN
AstraZeneca’s Real-World Study of Koselugo: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Real-World Study of Koselugo: Key Insights for Investors
19h ago
AZN
AstraZeneca’s Anifrolumab Study: Promising Real-world Insights for SLE Treatment
PremiumCompany Announcements
AstraZeneca’s Anifrolumab Study: Promising Real-world Insights for SLE Treatment
19h ago
AZN
AstraZeneca’s COPD Study: Potential Market Shifts Ahead
PremiumCompany Announcements
AstraZeneca’s COPD Study: Potential Market Shifts Ahead
19h ago
AZN
AstraZeneca’s Anifrolumab: A Promising SLE Treatment for Pediatric Patients
PremiumCompany Announcements
AstraZeneca’s Anifrolumab: A Promising SLE Treatment for Pediatric Patients
19h ago
AZN
AstraZeneca’s Innovative Approach to Advanced Gastric Cancer: A Study Update
PremiumCompany Announcements
AstraZeneca’s Innovative Approach to Advanced Gastric Cancer: A Study Update
19h ago
AZN
AstraZeneca’s Benralizumab Trial: A New Hope for Pediatric Asthma
PremiumCompany AnnouncementsAstraZeneca’s Benralizumab Trial: A New Hope for Pediatric Asthma
19h ago
AZN
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for Severe Asthma Treatment
Premium
Company Announcements
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for Severe Asthma Treatment
19h ago
AZN
AstraZeneca’s CRT Study in Russia: A Step Forward in Lung Cancer Treatment
Premium
Company Announcements
AstraZeneca’s CRT Study in Russia: A Step Forward in Lung Cancer Treatment
19h ago
AZN
AstraZeneca’s REBECCA Study: Real-World Insights into Early Breast Cancer Management
PremiumCompany Announcements
AstraZeneca’s REBECCA Study: Real-World Insights into Early Breast Cancer Management
19h ago
AZN
AstraZeneca’s Ravulizumab Study: A Potential Game-Changer for Myasthenia Gravis Treatment
PremiumCompany Announcements
AstraZeneca’s Ravulizumab Study: A Potential Game-Changer for Myasthenia Gravis Treatment
19h ago
AZN
FibroGen completes sale of FibroGen China to AstraZeneca for $220M
PremiumThe Fly
FibroGen completes sale of FibroGen China to AstraZeneca for $220M
2d ago
AZN
FGEN
Johnson & Johnson (JNJ) Says Trial Shows Its Heart Pump Could Keep Patients Alive Longer
PremiumMarket News
Johnson & Johnson (JNJ) Says Trial Shows Its Heart Pump Could Keep Patients Alive Longer
2d ago
AZN
JNJ
AstraZeneca’s Promising Non-Oncology Pipeline and Baxdrostat’s Market Potential Drive Buy Rating
PremiumRatingsAstraZeneca’s Promising Non-Oncology Pipeline and Baxdrostat’s Market Potential Drive Buy Rating
2d ago
AZN
AstraZeneca: Strong Market Position and Growth Potential Justify Buy Rating
Premium
Ratings
AstraZeneca: Strong Market Position and Growth Potential Justify Buy Rating
3d ago
AZN
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Potential and Strategic Positioning
Premium
Ratings
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Potential and Strategic Positioning
3d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >